International Pharmacovigilance Day

Pharmacovigilance Today: Back to Business!

Pharmacovigilance has been under unprecedented stress from a worldwide pandemic situation causing fundamental challenges and changes to its operations and not least to the availability of the PV professionals to fulfill existing and new roles. Underneath all these new world-changing demands lie the ever-demanding challenges of adapting the pharmacovigilance systems and operations to a globally diverse regulatory environment, like implementation of a new Clinical Trial Regulation, a new Medical Device legislation, technological advancements, automations and a new Eudravigilance implementation of the ISO/ICH E2B(R3) ICSR standard and guideline.
The pharmacovigilance landscape is subject to change and this calls for bringing PV professionals together to share views, concerns, challenges, and experiences of the matters that happen in the PV and regulatory environment.

In this conference you will not only hear from the experts, but we will stimulate interaction amongst the audience to learn from each other. We all cope with similar company and regulatory challenges, so why not learn from each other?

The fourth edition of the International Pharmacovigilance Day, organized by LS Academy, will be a really interactive conference and it will focus on the following topics, among others:

- Implementation of the EU CTR / CTIS
- Local pharmacovigilance: the link between Headquarter and affiliates
- Non-EU PSMFs and QPPVs: best practices
- Evolving PV landscape in times of pandemic
- Social media monitoring
- Mergers and acquisitions: PV system integrations
- PV audits and inspections
- QMS and relevant KPIs
- Risk management: digital vs paper materials
- PV Technologies and automations

Don’t miss the opportunity to update your knowledge, collect new contacts and discuss with other PV professionals coming from all over Europe.
It will be a pleasure to meet each other in Madrid on September 12th and 13th, 2022.

Scientific Board

• Martijn van de Leur, Head of Global PV at Biomapas (Chair of the Scientific Board)
• Martijn Dahlhaus, Head of Country PV, WorldWide Patient Safety at Bristol-Myers Squibb
• Jørgen Matz, Head of Global Pharmacovigilance & Drug Safety, EU QPPV at InsudPharma

Who should attend?

The conference program is designed for healthcare professionals or pharmacists in safety surveillance units in the pharmaceutical industry or regulatory agencies, either as specialists or managers, QPPVs, inspectors and QA personnel including auditors, employees in regulatory affairs units with close relations to pharmacovigilance, sponsors, vendors and CROs, representatives from patient organizations.